Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06188260 | Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease | PHASE2 | COMPLETED | 31 | — | — | Jan 16, 2024 | Nov 4, 2024 | Dec 2, 2024 | 1 | Hong Kong |
Change in OSDI score at 2-week visit
| Arm | Type | Description |
|---|---|---|
| Dry eye participants | EXPERIMENTAL | Participants aged 20 years or above, with OSDI score between 12-32, and with either of the following positive signs: 1) corneal staining; 2) NITBUT\<10s; 3) osmolarity \>=308, or difference \>8 |
| Name | Type | Description |
|---|---|---|
| Systane COMPLETE Lubricant Eye Drops | DRUG | Active Ingredients: Propylene Glycol 0.6% Purpose: Lubricant |
Inclusion Criteria: 1. Age 20-50 years old 2. Best corrected distance visual acuity ≥ 6/9 3. Mild to moderate OSDI score 13-32 4. Any one of the objective test positive (NITBUT/Corneal fluorescein staining/Tear osmolarity) Exclusion Criteria: 1. Any active ocular infections 2. Inflammations or an...